Redhill Biopharma
RDHL
$2.41
Share price
-13.31%
Change (1 day)
-77.33%
Change (1 year)
Categories
EPS for Redhill Biopharma (RDHL)
EPS in 2023 (TTM): -$3.74
According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -$3.74. In 2022 the company made an earnings per share (EPS) of -$48.00 an increase over its 2021 EPS that were of -$84.00.
EPS history for Redhill Biopharma from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.74 | -92.2% |
| 2022 | -$48.00 | -42.86% |
| 2021 | -$84.00 | 0% |
| 2020 | -$84.00 | 61.54% |
| 2019 | -$52.00 | -23.53% |
| 2018 | -$68.00 | -32% |
| 2017 | -$100.00 | 13.64% |
| 2016 | -$88.00 | 9.12% |
| 2015 | -$80.64 | 68.01% |
| 2014 | -$48.00 | -25.93% |
| 2013 | -$64.80 | -19% |
| 2012 | -$80.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $3.18 | -184.99% | 🇫🇷 France |
 | $1.82 | -148.68% | 🇺🇸 USA |
 | $3.50 | -193.55% | 🇬🇧 UK |
 | $0.61 | -116.30% | 🇮🇱 Israel |
 | -$2.00 | -46.55% | 🇮🇱 Israel |